The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Common Symptoms
Timeframe: 5 years
Common Laboratory Abnormalities
Timeframe: 5 years
Treatment
Timeframe: 5 years
Survival
Timeframe: 5 years
Identify patient subtypes
Timeframe: 4 years
Identify clinical outcome measures
Timeframe: 4 years
Identify clinical biomarkers
Timeframe: 4 years
Joshua Brandstadter, MD, PhD, MSc